A comparative study of blood removal therapy followed by bharangi extract nebulization and bharangi extract nebulization in bronchial asthma

A randomized comparative clinical study to evaluate the combined effect of siravyadha followed by bharangi arka nebulization with the standard group bharangi arka nebulization in tamaka shwasa (bronchial asthma)

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037807

Enrollment

Registered

2021-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: A randomized comparative clinical study: 40 Subjects fulfilling diagnostics and inclusion criteria will be selected by convenience sampling method and will be treated in two groups of 2

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mild and moderate grade of Bronchial Asthma as per GINA 2. Subjects with Hb more than 10 gm percent 3. Subjects with normal clotting and bleeding time

Exclusion criteria

Exclusion criteria: 1. Subjects who are known case of Tuberculosis Emphysema COPD 2. Subjects who are known case of Cardiac Diseases 3. Subjects who are known case of HIV and HBsAg 4. Subjects with uncontrolled Diabetes Mellitus and Hypertension. 5. Subjects with Bleeding Disorders

Design outcomes

Primary

Measure	Time frame
Samyak siravyadha lakshanas will be observed: 1. Laghava 2. Vedana shanti 3. Vyadhirvega kshaya 4. Mana prasadaTimepoint: Measures will be assessed by giving proper gradings before treatment, after siravyadha, 15 minutes after siravyadha, before nebulization, 15 minutes after nebulization in subjects of Group A In Group B, measures will be assessed before treatment and 15 minutes after nebulization	—

Measure

Time frame

Samyak siravyadha lakshanas will be observed: 1. Laghava 2. Vedana shanti 3. Vyadhirvega kshaya 4. Mana prasadaTimepoint: Measures will be assessed by giving proper gradings before treatment, after siravyadha, 15 minutes after siravyadha, before nebulization, 15 minutes after nebulization in subjects of Group A In Group B, measures will be assessed before treatment and 15 minutes after nebulization

—

Secondary

Measure	Time frame
The effect of the therapy will be assessed on the basis of relief of following signs and symptoms of Tamaka Shwasa which will be assigned suitable scores(GINA scale): 1. Gurukuraka 2. Kasa 3. Teevravega Shwasa 4. Peenasa 5. ShushkasyaTimepoint: Measures will be assessed by giving proper gradings before treatment, after siravyadha, 15 minutes after siravyadha, before nebulization, 15 minutes after nebulization in subjects of Group A In Group B, measures will be assessed before treatment and 15 minutes after nebulization	—

Measure

Time frame

The effect of the therapy will be assessed on the basis of relief of following signs and symptoms of Tamaka Shwasa which will be assigned suitable scores(GINA scale): 1. Gurukuraka 2. Kasa 3. Teevravega Shwasa 4. Peenasa 5. ShushkasyaTimepoint: Measures will be assessed by giving proper gradings before treatment, after siravyadha, 15 minutes after siravyadha, before nebulization, 15 minutes after nebulization in subjects of Group A In Group B, measures will be assessed before treatment and 15 minutes after nebulization

—

Countries

India

Contacts

Public ContactDrAshviini KumarM

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

pg19147@sdmcahhassan.org9416842630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026